Zobrazeno 1 - 10 of 36 pro vyhledávání: '"Kubota-Ishida N"'
1
Akademický článek
Antidermatophyte activity and PK/PD of ME1111 in a guinea pig model of tinea corporis.
Autor: Takei-Masuda N; Meiji Seika Pharma Co., Ltd., Tokyo, Japan. naomi.masuda@meiji.com., Nagira Y; Meiji Seika Pharma Co., Ltd., Tokyo, Japan., Kubota-Ishida N; Meiji Seika Pharma Co., Ltd., Tokyo, Japan., Chikada T; Meiji Seika Pharma Co., Ltd., Tokyo, Japan., Tabata Y; Meiji Seika Pharma Co., Ltd., Tokyo, Japan., Maebashi K; Meiji Seika Pharma Co., Ltd., Tokyo, Japan.
Publikováno v: The Journal of antibiotics [J Antibiot (Tokyo)] 2024 Aug; Vol. 77 (8), pp. 533-539. Date of Electronic Publication: 2024 May 20.
Zobrazit plný text záznamu
2
Akademický článek
ME3183, a novel phosphodiesterase-4 inhibitor, exhibits potent anti-inflammatory effects and is well tolerated in a non-clinical study.
Autor: Kubota-Ishida N; R&D Division, Meiji Seika Pharma Co., Ltd., 2-4-16, Kyobashi, Chuo-ku, Tokyo, 104-8002, Japan. Electronic address: natsuki.ishida@meiji.com., Kaji C; R&D Division, Meiji Seika Pharma Co., Ltd., 2-4-16, Kyobashi, Chuo-ku, Tokyo, 104-8002, Japan., Matsumoto S; R&D Division, Meiji Seika Pharma Co., Ltd., 2-4-16, Kyobashi, Chuo-ku, Tokyo, 104-8002, Japan., Wakabayashi T; R&D Division, Meiji Seika Pharma Co., Ltd., 2-4-16, Kyobashi, Chuo-ku, Tokyo, 104-8002, Japan., Matsuhira T; R&D Division, Meiji Seika Pharma Co., Ltd., 2-4-16, Kyobashi, Chuo-ku, Tokyo, 104-8002, Japan., Okura I; R&D Division, Meiji Seika Pharma Co., Ltd., 2-4-16, Kyobashi, Chuo-ku, Tokyo, 104-8002, Japan., Cho N; R&D Division, Meiji Seika Pharma Co., Ltd., 2-4-16, Kyobashi, Chuo-ku, Tokyo, 104-8002, Japan., Isshiki S; R&D Division, Meiji Seika Pharma Co., Ltd., 2-4-16, Kyobashi, Chuo-ku, Tokyo, 104-8002, Japan., Kumura K; R&D Division, Meiji Seika Pharma Co., Ltd., 2-4-16, Kyobashi, Chuo-ku, Tokyo, 104-8002, Japan., Tabata Y; R&D Division, Meiji Seika Pharma Co., Ltd., 2-4-16, Kyobashi, Chuo-ku, Tokyo, 104-8002, Japan.
Publikováno v: European journal of pharmacology [Eur J Pharmacol] 2024 Jan 05; Vol. 962, pp. 176202. Date of Electronic Publication: 2023 Nov 22.
Zobrazit plný text záznamu
3
Akademický článek
Anti-inflammatory effects of a novel phosphodiesterase-4 inhibitor, AA6216, in mouse dermatitis models.
Autor: Kubota-Ishida N; Pharmaceutical Research Center, Meiji Seika Pharma Co., Ltd., 760 Morooka-cho, Kohoku-ku, Yokohama, 222-8567, Japan. Electronic address: natsuki.ishida@meiji.com., Matsuhira T; Pharmaceutical Research Center, Meiji Seika Pharma Co., Ltd., 760 Morooka-cho, Kohoku-ku, Yokohama, 222-8567, Japan., Kaji C; Pharmaceutical Research Center, Meiji Seika Pharma Co., Ltd., 760 Morooka-cho, Kohoku-ku, Yokohama, 222-8567, Japan., Kikuchi C; Pharmaceutical Research Center, Meiji Seika Pharma Co., Ltd., 760 Morooka-cho, Kohoku-ku, Yokohama, 222-8567, Japan., Tabata Y; Pharmaceutical Research Center, Meiji Seika Pharma Co., Ltd., 760 Morooka-cho, Kohoku-ku, Yokohama, 222-8567, Japan.
Publikováno v: European journal of pharmacology [Eur J Pharmacol] 2021 Sep 05; Vol. 906, pp. 174258. Date of Electronic Publication: 2021 Jun 15.
Zobrazit plný text záznamu
4
Akademický článek
A novel phosphodiesterase 4 inhibitor, AA6216, reduces macrophage activity and fibrosis in the lung.
Autor: Matsuhira T; Department of Respiratory Medicine and Allergology, Kindai University Faculty of Medicine, 377-2 Onohigashi, Osakasayama, Osaka, 589-8511, Japan; Pharmaceutical Research Center, Meiji Seika Pharma Co., Ltd., 760 Morooka-cho, Kohoku-ku, Yokohama, Kanagawa, 222-8567, Japan., Nishiyama O; Department of Respiratory Medicine and Allergology, Kindai University Faculty of Medicine, 377-2 Onohigashi, Osakasayama, Osaka, 589-8511, Japan. Electronic address: nishiyama_o@yahoo.co.jp., Tabata Y; Pharmaceutical Research Center, Meiji Seika Pharma Co., Ltd., 760 Morooka-cho, Kohoku-ku, Yokohama, Kanagawa, 222-8567, Japan., Kaji C; Pharmaceutical Research Center, Meiji Seika Pharma Co., Ltd., 760 Morooka-cho, Kohoku-ku, Yokohama, Kanagawa, 222-8567, Japan., Kubota-Ishida N; Pharmaceutical Research Center, Meiji Seika Pharma Co., Ltd., 760 Morooka-cho, Kohoku-ku, Yokohama, Kanagawa, 222-8567, Japan., Chiba Y; Division of Biostatistics, Clinical Research Center, Kindai University Faculty of Medicine, 377-2 Onohigashi, Osakasayama, Osaka, 589-8511, Japan., Sano H; Department of Respiratory Medicine and Allergology, Kindai University Faculty of Medicine, 377-2 Onohigashi, Osakasayama, Osaka, 589-8511, Japan., Iwanaga T; Department of Respiratory Medicine and Allergology, Kindai University Faculty of Medicine, 377-2 Onohigashi, Osakasayama, Osaka, 589-8511, Japan., Tohda Y; Department of Respiratory Medicine and Allergology, Kindai University Faculty of Medicine, 377-2 Onohigashi, Osakasayama, Osaka, 589-8511, Japan.
Publikováno v: European journal of pharmacology [Eur J Pharmacol] 2020 Oct 15; Vol. 885, pp. 173508. Date of Electronic Publication: 2020 Aug 25.
Zobrazit plný text záznamu
6
Akademický článek
In Vitro Human Onychopharmacokinetic and Pharmacodynamic Analyses of ME1111, a New Topical Agent for Onychomycosis.
Autor: Kubota-Ishida N; Meiji Seika Pharma Co., Ltd., Tokyo, Japan natsuki.ishida@meiji.com., Takei-Masuda N; Meiji Seika Pharma Co., Ltd., Tokyo, Japan., Kaneda K; Meiji Seika Pharma Co., Ltd., Tokyo, Japan., Nagira Y; Meiji Seika Pharma Co., Ltd., Tokyo, Japan., Chikada T; Meiji Seika Pharma Co., Ltd., Tokyo, Japan., Nomoto M; Meiji Seika Pharma Co., Ltd., Tokyo, Japan., Tabata Y; Meiji Seika Pharma Co., Ltd., Tokyo, Japan., Takahata S; Meiji Seika Pharma Co., Ltd., Tokyo, Japan., Maebashi K; Meiji Seika Pharma Co., Ltd., Tokyo, Japan., Hui X; University of California, San Francisco, San Francisco, California, United States., Maibach HI; University of California, San Francisco, San Francisco, California, United States.
Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2017 Dec 21; Vol. 62 (1). Date of Electronic Publication: 2017 Dec 21 (Print Publication: 2018).
Zobrazit plný text záznamu
7
Akademický článek
New and Emerging Oral/Topical Small-Molecule Treatments for Psoriasis.
Autor: Carmona-Rocha, Elena1,2,3 (AUTHOR) ecarmona@santpau.cat, Rusiñol, Lluís1,2,3 (AUTHOR) lrusinol@santpau.cat, Puig, Lluís1,2,3 (AUTHOR) lpuig@santpau.cat
Publikováno v: Pharmaceutics. Feb2024, Vol. 16 Issue 2, p239. 36p.
Zobrazit plný text záznamu
8
Akademický článek
Decoding the Mechanism of Magnolol in Treating Asthma Based on Network Pharmacology and Transcriptomic Analysis.
Autor: LUO, L.1, WANG, J. Y.1, XIONG, A. Y.1, LIU, J. L.1, LIU, Y.1, LIU, S. B.1, XIONG, Y.2, HE, X.1, LI, G. P.1 lzlgp@163.com
Publikováno v: Indian Journal of Pharmaceutical Sciences. Sep/Oct2023, Vol. 85 Issue 5, p1373-1387. 15p.
Zobrazit plný text záznamu
9
Akademický článek
Vitronectin Destroyed Intestinal Epithelial Cell Differentiation through Activation of PDE4-Mediated Ferroptosis in Inflammatory Bowel Disease.
Autor: Pan, Wenxu1,2 (AUTHOR), Xiang, Li2 (AUTHOR), Liang, Xinhua2 (AUTHOR), Du, Wenjun2 (AUTHOR), Zhao, Junhong2 (AUTHOR), Zhang, Song3 (AUTHOR), Zhou, Xuan4 (AUTHOR), Geng, Lanlan2 (AUTHOR), Gong, Sitang1,2 (AUTHOR), Xu, Wanfu2 (AUTHOR)
Publikováno v: Mediators of Inflammation. 7/19/2023, p1-16. 16p.
Zobrazit plný text záznamu
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje